Beatriz Perdiguero

2.9k total citations
46 papers, 1.6k citations indexed

About

Beatriz Perdiguero is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Beatriz Perdiguero has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Virology, 28 papers in Immunology and 17 papers in Epidemiology. Recurrent topics in Beatriz Perdiguero's work include HIV Research and Treatment (20 papers), Immunotherapy and Immune Responses (16 papers) and Poxvirus research and outbreaks (15 papers). Beatriz Perdiguero is often cited by papers focused on HIV Research and Treatment (20 papers), Immunotherapy and Immune Responses (16 papers) and Poxvirus research and outbreaks (15 papers). Beatriz Perdiguero collaborates with scholars based in Spain, United States and Switzerland. Beatriz Perdiguero's co-authors include Mariano Estéban, Carmen Gómez, Juan García‐Arriaza, Rafael Blasco, Carlos Óscar S. Sorzano, Mauro Di Pilato, Ernesto Mejías‐Pérez, José Luis Nájera, Marı́a M. Lorenzo and Lucas Sánchez-Sampedro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Beatriz Perdiguero

43 papers receiving 1.5k citations

Peers

Countries citing papers authored by Beatriz Perdiguero

Since Specialization

Citations

This map shows the geographic impact of Beatriz Perdiguero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Perdiguero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Perdiguero more than expected).

Fields of papers citing papers by Beatriz Perdiguero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Perdiguero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Perdiguero. The network helps show where Beatriz Perdiguero may publish in the future.

Co-authorship network of co-authors of Beatriz Perdiguero

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Perdiguero. A scholar is included among the top collaborators of Beatriz Perdiguero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Perdiguero. Beatriz Perdiguero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2 2025 ·Vaccines ·Juan García‐Arriaza, (unknown), Patricia Pérez, Rocío Coloma, Beatriz Perdiguero, (unknown), Laura Marcos-Villar, (unknown), (unknown), Carlos Óscar S. Sorzano, Mariano Estéban, Carmen Gómez, Susana Guerra	0
2	B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2 2024 ·Vaccines ·Beatriz Perdiguero, (unknown), Laura Marcos-Villar, (unknown), María López‐Bravo, José Ramón Valverde, Carlos Óscar S. Sorzano, (unknown), Rocío Coloma, Mariano Estéban, Susana Guerra, Carmen Gómez	1
3	Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein 2023 ·Frontiers in Immunology ·Beatriz Perdiguero, (unknown), Carmen Gómez, David Peterhoff, (unknown), Carlos Óscar S. Sorzano, (unknown), (unknown), (unknown), Benedikt Asbach, S.-W Ding, Dorotheé von Laer, Yves Lévy, Giuseppe Pantaleo, Janine Kimpel, Mariano Estéban, Ralf Wagner	1
4	The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses 2023 ·Vaccines ·(unknown), Lorna Leal, Carmen Gómez, (unknown), Elena Aurrecoechea, (unknown), Berta Torres, Alexy Inciarte, Beatriz Perdiguero, Mariano Estéban, Felipe García, Montserrat Plana	6
5	An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Beatriz Perdiguero, Rocío Coloma, (unknown), Laura Marcos-Villar, (unknown), Carlos Óscar S. Sorzano, Mariano Estéban, Carmen Gómez, Susana Guerra	9
6	Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen 2021 ·Vaccines ·Carmen Gómez, Beatriz Perdiguero, (unknown), Laura Marcos-Villar, (unknown), Lorna Leal, Carlos Óscar S. Sorzano, (unknown), Montserrat Plana, Felipe García, Mariano Estéban	17
7	Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus 2019 ·Vaccines ·Beatriz Perdiguero, (unknown), Carlos Óscar S. Sorzano, (unknown), (unknown), Mariano Estéban, Carmen Gómez	5
8	A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses 2019 ·Viruses ·Beatriz Perdiguero, (unknown), Carlos Óscar S. Sorzano, (unknown), (unknown), Mariano Estéban, Carmen Gómez	12
9	Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B 2018 ·Viruses ·Beatriz Perdiguero, (unknown), (unknown), Carlos Óscar S. Sorzano, José Ramón Valverde, Mariano Estéban, Carmen Gómez	9
10	Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways 2017 ·Viruses ·Carmen Gómez, Beatriz Perdiguero, (unknown), Carlos Óscar S. Sorzano, Mariano Estéban	8
11	A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART 2015 ·PLoS ONE ·Carmen Gómez, Beatriz Perdiguero, Juan García‐Arriaza, Victoria Cepeda, Carlos Óscar S. Sorzano, Beatriz Mothe, Javier López Jiménez, María Ángeles Muñoz‐Fernández, José M. Gatell, Juan Carlos López Bernaldo de Quirós, Christian Brander, Felipe García, Mariano Estéban	18
12	Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C 2013 ·PLoS ONE ·Beatriz Perdiguero, Carmen Gómez, Mauro Di Pilato, Carlos Óscar S. Sorzano, Julie Delaloye, Thierry Roger, Thierry Calandra, Giuseppe Pantaleo, Mariano Estéban	22
13	Involvement of the Cellular Phosphatase DUSP1 in Vaccinia Virus Infection 2013 ·PLoS Pathogens ·(unknown), Beatriz Perdiguero, Carmen Gómez, (unknown), Carmé Caelles, Carlos Óscar S. Sorzano, Mariano Estéban	17
14	Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein 2012 ·PLoS ONE ·Juliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, Ana M. Rodríguez, (unknown), Beatriz Perdiguero, Carmen Gómez, Mariano Estéban, Gabriela Calamante, María Magdalena Gherardi	52
15	Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C 2012 ·PLoS ONE ·Carmen Gómez, Beatriz Perdiguero, Victoria Jiménez, Abdelali Filali‐Mouhim, Khader Ghneim, Elias K. Haddad, (unknown), Julie Delaloye, Alexandre Harari, Thierry Roger, (unknown), Rafick‐Pierre Sékaly, Cornelis J.M. Melief, Thierry Calandra, Federica Sallusto, Antonio Lanzavecchia, Ralf Wagner, Giuseppe Pantaleo, Mariano Estéban	20
16	Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens 2012 ·PLoS ONE ·Beatriz Perdiguero, Carmen Gómez, José Luis Nájera, Carlos Óscar S. Sorzano, Julie Delaloye, Rubén González-Sanz, Victoria Jiménez, Thierry Roger, Thierry Calandra, Giuseppe Pantaleo, Mariano Estéban	30
17	The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens 2011 ·Journal of Virology ·Carmen Gómez, José Luis Nájera, Beatriz Perdiguero, Juan García‐Arriaza, Carlos Óscar S. Sorzano, Victoria Jiménez, Rubén González-Sanz, Javier López Jiménez, María Ángeles Muñoz‐Fernández, Juan Carlos López Bernaldo de Quirós, Alberto C. Guardo, Felipe García, José M. Gatell, Montserrat Plana, Mariano Estéban	59
18	MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer 2011 ·Current Gene Therapy ·Carmen Gómez, José Luis Nájera, Magdalena Krupa, Beatriz Perdiguero, Mariano Estéban	90
19	Improved NYVAC-Based Vaccine Vectors 2011 ·PLoS ONE ·Karen V. Kibler, Carmen Gómez, Beatriz Perdiguero, Shukmei Wong, Trung Huynh, Susan Holechek, William Arndt, Victoria Jiménez, Rubén González-Sanz, Karen L. Denzler, Elias K. Haddad, Ralf Wagner, Rafick‐Pierre Sékaly, James Tartaglia, Giuseppe Pantaleo, Bertram L. Jacobs, Mariano Estéban	45
20	The Interferon System and Vaccinia Virus Evasion Mechanisms 2009 ·Journal of Interferon & Cytokine Research ·Beatriz Perdiguero, Mariano Estéban	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact